文献
J-GLOBAL ID:202202240755353807
整理番号:22A1177974
好酸球増加症候群のメポリズマブ治療患者におけるベースライン治療とフレア減少との関連【JST・京大機械翻訳】
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
著者 (7件):
Reiter Andreas
(1Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany)
,
Lefevre Guillaume
(2Universite de Lille, Centre Hospitalier Universitaire de Lille (CHU Lille), Institut d’Immunologie, Centre de Reference National des Syndromes Hypereosinophiliques (CEREO), Institute for Translational Research in Inflammation Infinite-U1286. Inserm, Lille, France)
,
Cid Maria C.
(3Department of Autoimmune Diseases, Institut d’Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain)
,
Kwon Namhee
(4Respiratory Research and Development, GlaxoSmithKline (GSK), Brentford, United Kingdom)
,
Mavropolou Eleni
(5Clinical Statistics, GlaxoSmithKline (GSK), Brentford, United Kingdom)
,
Yancey Steven W.
(6Respiratory Therapeutic Area, GlaxoSmithKline (GSK), Research Triangle Park, NC, United States)
,
Steinfeld Jonathan
(7Respiratory Research and Development, GlaxoSmithKline (GSK), Collegeville, PA, United States)
資料名:
Frontiers in Immunology (Web)
(Frontiers in Immunology (Web))
巻:
13
ページ:
840974
発行年:
2022年
JST資料番号:
U7074A
ISSN:
1664-3224
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)